Novartis buys share to expand business
Novartis AG will expand its human vaccine business in China by acquiring an 85-percent stake in a local vaccine company for 850 million yuan (US$125 million) in cash.
With the investment in Zhejiang Tianyuan Bio-Pharmaceutical Co, the Switzerland-based drug maker expects to boost its limited presence in the domestic vaccine industry, the company said in a [...]